Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter June 1, 2005

Vascular Endothelial Growth Factor (VEGF) and Its Receptors in Tumor-Bearing Dogs

  • Patrick Scheidegger , Wolfgang Weiglhofer , Stéphanie Suarez , Barbara Kaser-Hotz , Rudolf Steiner , Kurt Ballmer-Hofer and Rolf Jaussi
From the journal Biological Chemistry

Abstract

The molecular biology of the angiogenic growth factor, vascular endothelial growth factor (VEGF), has been studied in the dog. All major isoforms of VEGF are present in the dog. The amino acid sequences are identical between human and dog in the loop regions that are responsible for receptor binding. Accordingly, the VEGF receptors of dogs and humans are very similar and permit functional exchange of the growth factor. Here we show that canine VEGF activates human endothelial cells to the same extent as human VEGF. Similarly, the two proteins display identical cell binding properties. The VEGF receptor 1 (Flt-1) shows the same alternative splicing in humans and dogs and is overexpressed in the majority of tumors in both species. VEGF occurs also in canine tumors in similar relative quantities as in human malignancies. Based on the literature and our study we suggest that the molecular biology and the function of the VEGF signaling system are virtually identical in humans and canines and in healthy as well as in disease conditions.

:
Published Online: 2005-06-01
Published in Print: 1999-12-20

Copyright © 1999 by Walter de Gruyter GmbH & Co. KG

Downloaded on 13.1.2025 from https://www.degruyter.com/document/doi/10.1515/BC.1999.187/html
Scroll to top button